Breaking News Instant updates and real-time market news.

FMC Corporation says lithium strategy focus is on downstream segment

30

Nov

FMCFMC Corporation

$55.40

0.6 (1.09%)

11/28/16

PIPR

11/28/16UPGRADETarget $51PIPRNeutral

FMC Corporation upgraded to Neutral from Underweight at Piper Jaffray

Piper Jaffray analyst Brett Wong upgraded FMC Corporation and others in the Agriculture space to Neutral saying investors will likely continue to pay "lofty multiples" since a bottom of the cycle is close. The analyst raised his price target for the shares to $51 from $45.

11/04/16

11/04/16UPGRADETarget $57Outperform

FMC Corporation upgraded to Outperform at Credit Suisse

As previously reported, Credit Suisse upgraded FMC Corporation to Outperform from Neutral and raised its price target to $57 from $48. Analyst Christopher Parkinson still has modest concerns regarding ag headwinds but said they are offset from enhanced distribution channels, dynamic pricing models and upside from lithium.

11/04/16

FBCO

11/04/16UPGRADEFBCOOutperform

FMC Corporation upgraded to Outperform from Neutral at Credit Suisse

05/19/16

JEFF

05/19/16NO CHANGETarget $95JEFFHold

Jefferies views Bayer buyout of Monsanto as 'relatively unlikely'

After Monsanto (MON) confirmed an unsolicited offer from Bayer (BAYRY), Jefferies analyst Laurence Alexander says he still believes a transaction is "relatively unlikely." The analyst expects Monsanto to object to Bayer's offer given its conviction in its research and development pipeline and longer-term competitive advantages. Shares of Syngenta (SYT) and DuPont (DD) could be pressured as regulatory scrutiny is likely to intensify should Monsanto get acquired, and BASF (BASFY) could sell off on investor concerns of a potential counter-bid, Alexander tells investors in a research note. On the other hand, he sees a potential Monsanto takeover as positive for shares of Novozymes (NVZMY) and FMC Corporation (FMC). "A further roll-up of 'specialty generic' agrichemical assets could entice capital, and FMC would be a plausible anchor for such an attempt," the analyst writes. He has a Hold rating on Monsanto with a $95 price target.